SCHEMBL4006653

SCHEMBL4006653

CC1(C)N=Nc2ccc[c]c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8133846 0.67 MEN1 (0.39)
SCHEMBL8164070 0.58 ALDH1A1 (0.33)
SCHEMBL18788600 0.58 PDK2 (0.48)
SCHEMBL8308882 0.57 TP53 (0.32)
SCHEMBL148320 0.56 PGR (0.35)
SCHEMBL1273324 0.55
SCHEMBL1273311 0.55
SCHEMBL23295732 0.55 S100A4 (0.33)
SCHEMBL2410642 0.55
SCHEMBL29180293 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1680406-A1 N-SUBSTITUTED BENZENE SULFONAMIDES Elan Pharmaceuticals, Inc. (US) 2006-07-19 EP claimed
WO-2005042489-A1 N-SUBSTITUTED BENZENE SULFONAMIDES ELAN PHARMACEUTICALS, INC. (US) 2005-05-12 WO claimed
US-7569562-B2 N-substituted heterocyclic sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2009-08-04 US disclosed
EP-1838701-A1 N-SUBSTITUTED HETEROCYCLIC SULFONAMIDES Elan Pharmaceuticals Inc. (US) 2007-10-03 EP disclosed
US-20070191341-A1 N-Substituted Benzene Sulfonamides ELAN PHARMACEUTICALS, INC. 2007-08-16 US disclosed
US-20060270657-A1 N-substituted heterocyclic sulfonamides ELAN PHARMACEUTICALS, INC. 2006-11-30 US disclosed
WO-2006078753-A1 N-SUBSTITUTED HETEROCYCLIC SULFONAMIDES ELAN PHARMACEUTICALS, INC. (US) 2006-07-27 WO disclosed
EP-1680406-A1 N-SUBSTITUTED BENZENE SULFONAMIDES Elan Pharmaceuticals, Inc. (US) 2006-07-19 EP disclosed
WO-2005042489-A1 N-SUBSTITUTED BENZENE SULFONAMIDES ELAN PHARMACEUTICALS, INC. (US) 2005-05-12 WO disclosed